IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation
ABSTRACTImmune checkpoint inhibitors that overcome T cell suppressive mechanisms in tumors have revolutionized the treatment of cancer but are only efficacious in a small subset of patients. Targeting suppressive mechanisms acting on innate immune cells could significantly improve the incidence of c...
Saved in:
Main Authors: | John P. Dowling (Author), Pavel A. Nikitin (Author), Fang Shen (Author), Halley Shukla (Author), James P. Finn (Author), Nirja Patel (Author), Cezary Swider (Author), Jamie L. Bingaman-Steele (Author), Chris Nicolescu (Author), Eden L Sikorski (Author), Evan J. Greenawalt (Author), Michael J. Morin (Author), Matthew K. Robinson (Author), Karen Lundgren (Author), Benjamin C. Harman (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combinatorial Approaches to Enhance Anti-Tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
Published: (2019) -
Tumor lysis syndrome and collateral immune activation in dual checkpoint blockade
by: Risa Konishi, et al.
Published: (2021) -
Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy
by: Ge Qin, et al.
Published: (2024) -
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
by: Mingxia Zhao, et al.
Published: (2019) -
Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors
by: Qiuyu Wu, et al.
Published: (2023)